MedTrace Logo

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

NCT03932578 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-10-07

No results posted yet for this study

Summary

The aim of this study is to evaluate the prophylactic use of low dose atropine and comparing it to metoclopramide for reducing intraoperative nausea and vomiting during cesarean section under spinal anesthesia

Conditions

Interventions

DRUG

Atropine sulfate

Patients will receive intrathecal 100 μg of a 1 mg/ml preservative-free atropine sulfate solution

DRUG

Metoclopramide

Patients will receive IV metoclopramide 10 mg in 2 ml

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Tamer Elmetwally, MD · Mansoura University

  • Mohamed S Abdelhafez, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-05
Primary Completion
2019-08-28
Completion
2019-08-28

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03932578 on ClinicalTrials.gov